1. Home
  2. ENTG vs VTRS Comparison

ENTG vs VTRS Comparison

Compare ENTG & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTG
  • VTRS
  • Stock Information
  • Founded
  • ENTG 1966
  • VTRS 1961
  • Country
  • ENTG United States
  • VTRS United States
  • Employees
  • ENTG N/A
  • VTRS N/A
  • Industry
  • ENTG Plastic Products
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • ENTG Industrials
  • VTRS Health Care
  • Exchange
  • ENTG Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • ENTG 13.9B
  • VTRS 11.1B
  • IPO Year
  • ENTG 2000
  • VTRS N/A
  • Fundamental
  • Price
  • ENTG $93.01
  • VTRS $10.37
  • Analyst Decision
  • ENTG Buy
  • VTRS Hold
  • Analyst Count
  • ENTG 11
  • VTRS 6
  • Target Price
  • ENTG $107.09
  • VTRS $11.17
  • AVG Volume (30 Days)
  • ENTG 2.2M
  • VTRS 7.1M
  • Earning Date
  • ENTG 10-30-2025
  • VTRS 11-06-2025
  • Dividend Yield
  • ENTG 0.44%
  • VTRS 4.64%
  • EPS Growth
  • ENTG 60.99
  • VTRS N/A
  • EPS
  • ENTG 1.95
  • VTRS N/A
  • Revenue
  • ENTG $3,223,108,000.00
  • VTRS $14,115,700,000.00
  • Revenue This Year
  • ENTG $0.67
  • VTRS N/A
  • Revenue Next Year
  • ENTG $8.09
  • VTRS $1.61
  • P/E Ratio
  • ENTG $46.94
  • VTRS N/A
  • Revenue Growth
  • ENTG N/A
  • VTRS N/A
  • 52 Week Low
  • ENTG $60.75
  • VTRS $6.85
  • 52 Week High
  • ENTG $112.36
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • ENTG 52.51
  • VTRS 61.57
  • Support Level
  • ENTG $87.00
  • VTRS $10.30
  • Resistance Level
  • ENTG $94.80
  • VTRS $10.52
  • Average True Range (ATR)
  • ENTG 4.49
  • VTRS 0.21
  • MACD
  • ENTG -0.50
  • VTRS 0.05
  • Stochastic Oscillator
  • ENTG 51.17
  • VTRS 81.82

About ENTG Entegris Inc.

Entegris is a leading supplier of purification solutions and advanced materials. The vast majority of sales are to the semiconductor industry. The majority of revenue comes from semiconductor fabricators, but the company sells to all areas of the semiconductor manufacturing supply chain including equipment and engineering, chemicals and materials, and distributors. Entegris specializes in materials science and materials purity, both of which are crucial in the semiconductor manufacturing process.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: